Takeda Pharmaceutical
@takeda.co.jp
タケダは、常に患者さんを中心に考えるグローバルな研究開発型バイオ医薬品のリーディングカンパニーです。
Takeda Pharmaceutical's Company Logos


Takeda Pharmaceutical's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#E1242A
Alizarin Crimson
225, 36, 42
358, 76, 51
0, 84, 81, 12
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#5E0904
Red Oxide
94, 9, 4
3, 92, 19
0, 90, 96, 63
About Takeda Pharmaceutical
Takeda Pharmaceutical is a prominent Japanese pharmaceutical company that has made notable contributions to the field of healthcare over the years. Established in 1781, Takeda has a rich history of more than 240 years. Its headquarters are located in Chuo-ku, Osaka, Japan.
Takeda Pharmaceutical primarily focuses on the research and development, manufacturing, and marketing of pharmaceutical drugs. It offers a wide range of products and services, including prescription medicines, over-the-counter drugs, and vaccines. The company's main therapeutic areas of expertise are gastroenterology, oncology, central nervous system disorders, and vaccines.
Takeda operates on a global scale, with a strong presence in various countries around the world. The company has a number of noteworthy subsidiaries, joint ventures, and partnerships. Some of its major subsidiaries include Takeda Pharmaceuticals U.
S. A., Inc., Takeda Pharmaceuticals International AG, and Millennium Pharmaceuticals, Inc. Takeda formed a joint venture with London-based Shire Pharmaceuticals in 2019, expanding its global reach and enhancing its product portfolio.
In terms of market position, Takeda Pharmaceutical is one of the largest pharmaceutical companies globally. It generates a substantial amount of revenue from its operations. Takeda has a strong presence in key markets like the United States, Japan, and Europe.
It operates in a highly competitive industry and competes with other major global pharmaceutical companies such as Pfizer, Roche, and Novartis. Over the years, Takeda has achieved significant milestones and made strategic changes to ensure its growth. In 2011, the company acquired Nycomed, a Swiss pharmaceutical company, increasing its global footprint.
In 2018, Takeda made a landmark acquisition by purchasing Shire Pharmaceuticals, strengthening its position in the rare diseases market. As of the latest updates, Takeda Pharmaceutical continues to evolve and adapt to the changing healthcare landscape. The company remains committed to its mission of improving the health and well-being of people worldwide.
Takeda also seeks to develop innovative therapies and address unmet medical needs in various therapeutic areas, driven by its dedication to research and development. In conclusion, Takeda Pharmaceutical is a renowned Japanese pharmaceutical company with a long-standing history. It offers a wide range of products and services, operates globally, and competes with other major players in the industry.
Through strategic acquisitions and a commitment to innovation, Takeda continues to thrive in the evolving healthcare market
